Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2026-02-06 00:00:00 ET · period of report 2026-02-05 · accession 0001193125-26-041325 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-06 | 2026-02-05 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $37.32 | +2,679 | 24.9K | +12% | +$100.0K |
| DM | 2026-02-06 | 2026-02-05 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | -2,679 | 14.1K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-05 | M | A | 2,672 | $37.29 | 24,923 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Common | Common Stock | 2026-02-05 | M | A | 7 | $48.60 | 24,930 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-02-05 | M | D | 2,672 | $0.00 | 0 | D | $37.29 · 2020-12-02 to 2027-12-02 | 2,672 Common Stock | (F2) This option is fully vested and exercisable. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-02-05 | M | D | 7 | $0.00 | 14,054 | D | $48.60 · 2021-12-11 to 2028-12-11 | 7 Common Stock | (F2) This option is fully vested and exercisable. |